Intrexon | XON - Market Capitalization


Intrexon reported $1B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 210.86B 90.39B Apr/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Gilead Sciences USD 166.62B 14.34B Apr/2026
GlaxoSmithKline GBP 78.11B 3.75B Apr/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 21.96B 3.23B Apr/2026
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 231.75B 76B Apr/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Thermo Fisher Scientific USD 177.96B 4.7B Apr/2026
Veracyte USD 3.33B 627M Dec/2025
Xencor USD 1.09B 256M Dec/2025